Bonafide Women’s Health LLC recently added to its more than 50 women’s health supplement formulations by acquiring a proprietary SAM-e ingredient from Canadian firm MSI Methylation Sciences Inc.
MSI Methylation sold its S-adenosyl-L-methionine ingredient, a controlled-release tablet identified as MSI-195, after conducting a study on its safety and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?